| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1492 |
| Trial ID | NCT02243124 |
| Disease | Myelodysplastic Syndrome |
| Altered gene | P53 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | Aezea|Cenersen|EL625|Ol(1)p53 |
| Co-treatment | Dexamethasone |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | A Study of Aezea (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome |
| Year | 2014 |
| Country | United States |
| Company sponsor | Eleos, Inc. |
| Other ID(s) | MDS ELP9001 |
| Vector information | |||
|
|||
| Cohort1: dose level 1 | |||||||
|
|||||||
| Cohort2: dose level 2 | |||||||
|
|||||||
| Cohort3: dose level 3 | |||||||
|
|||||||